According to a recent LinkedIn post from Vektor Medical Inc, the company’s team is attending the HRS 2026 conference in Chicago and exhibiting its vMap technology in the main hall. The post highlights that vMap is positioned as a non‑invasive tool designed to give electrophysiologists actionable insights from ECG data without adding time, risk, or workflow complexity.
Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
The post also notes that several electrophysiologists will discuss their experience with vMap and emerging clinical evidence in a dedicated Rhythm Theater session. For investors, this presence suggests an effort to increase clinical adoption, gather real‑world feedback, and build physician advocacy, which could support future revenue growth and strengthen the company’s positioning in the electrophysiology and broader medtech market if interest translates into commercial traction.